Healthcare Realty Trust (NYSE:HR) has been given a $32.00 price target by SunTrust Banks in a research report issued to clients and investors on Monday. The firm presently has a “hold” rating on the real estate investment trust’s stock. SunTrust Banks’ price target points to a potential upside of 4.40% from the stock’s current price.

A number of other equities analysts also recently commented on HR. BMO Capital Markets restated a “buy” rating and issued a $34.00 target price on shares of Healthcare Realty Trust in a research note on Monday, October 2nd. KeyCorp restated a “sell” rating and issued a $25.00 target price on shares of Healthcare Realty Trust in a research note on Tuesday, September 26th. Zacks Investment Research upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research note on Monday, September 25th. Mizuho reaffirmed a “hold” rating and issued a $34.00 price target on shares of Healthcare Realty Trust in a research report on Sunday, November 5th. Finally, TheStreet cut shares of Healthcare Realty Trust from a “b” rating to a “c+” rating in a research report on Thursday, November 9th. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $33.00.

Healthcare Realty Trust (NYSE:HR) opened at $30.65 on Monday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.82 and a quick ratio of 2.82. The company has a market cap of $3,780.42, a PE ratio of 31.60, a price-to-earnings-growth ratio of 4.56 and a beta of 0.32. Healthcare Realty Trust has a one year low of $29.40 and a one year high of $36.25.

Healthcare Realty Trust (NYSE:HR) last issued its earnings results on Wednesday, November 1st. The real estate investment trust reported $0.38 EPS for the quarter, missing the Zacks’ consensus estimate of $0.39 by ($0.01). The company had revenue of $106.95 million during the quarter, compared to the consensus estimate of $108.97 million. Healthcare Realty Trust had a return on equity of 6.62% and a net margin of 26.70%. Healthcare Realty Trust’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.39 earnings per share. sell-side analysts anticipate that Healthcare Realty Trust will post 1.55 earnings per share for the current fiscal year.

In other Healthcare Realty Trust news, Director John Knox Singleton purchased 3,074 shares of the stock in a transaction dated Friday, November 10th. The stock was purchased at an average price of $32.55 per share, with a total value of $100,058.70. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Robert E. Hull sold 1,495 shares of the company’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $33.87, for a total transaction of $50,635.65. Following the completion of the sale, the executive vice president now directly owns 94,796 shares of the company’s stock, valued at approximately $3,210,740.52. The disclosure for this sale can be found here. Insiders sold a total of 16,847 shares of company stock valued at $551,491 in the last ninety days. Corporate insiders own 1.85% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. FMR LLC lifted its position in shares of Healthcare Realty Trust by 6.4% in the 2nd quarter. FMR LLC now owns 7,274,016 shares of the real estate investment trust’s stock worth $248,408,000 after purchasing an additional 434,895 shares during the period. State Street Corp lifted its position in Healthcare Realty Trust by 2.2% during the second quarter. State Street Corp now owns 5,887,196 shares of the real estate investment trust’s stock valued at $201,047,000 after acquiring an additional 127,663 shares during the last quarter. Northern Trust Corp lifted its position in Healthcare Realty Trust by 8.6% during the second quarter. Northern Trust Corp now owns 3,367,432 shares of the real estate investment trust’s stock valued at $114,997,000 after acquiring an additional 266,749 shares during the last quarter. Macquarie Group Ltd. lifted its position in Healthcare Realty Trust by 1.5% during the third quarter. Macquarie Group Ltd. now owns 1,963,775 shares of the real estate investment trust’s stock valued at $63,508,000 after acquiring an additional 28,287 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Healthcare Realty Trust by 2.8% during the third quarter. Dimensional Fund Advisors LP now owns 1,682,022 shares of the real estate investment trust’s stock valued at $54,397,000 after acquiring an additional 45,645 shares during the last quarter. 94.75% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://theolympiareport.com/2018/01/24/suntrust-banks-reiterates-32-00-price-target-for-healthcare-realty-trust-hr.html.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The Company owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States.

Analyst Recommendations for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.